$LGND
LIGAND PHARMACEUTICALS INC

2023 Q4 Form 10-Q Financial Statement

#000088616323000086 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q4
Revenue $28.10M $32.87M $50.38M
YoY Change -44.22% -50.27% -30.48%
Cost Of Revenue $1.641M $3.490M $21.61M
YoY Change -92.41% -75.34% 80.36%
Gross Profit $26.46M $29.38M $28.77M
YoY Change -8.02% -43.43% -52.44%
Gross Profit Margin 94.16% 89.39% 57.1%
Selling, General & Admin $15.99M $14.66M $31.13M
YoY Change -48.63% -15.96% 75.52%
% of Gross Profit 60.44% 49.9% 108.21%
Research & Development $5.488M $5.532M $9.197M
YoY Change -40.33% -74.9% -49.59%
% of Gross Profit 20.74% 18.83% 31.97%
Depreciation & Amortization $8.916M $8.600M $8.539M
YoY Change 4.42% -36.19% -35.16%
% of Gross Profit 33.7% 29.27% 29.68%
Operating Expenses $29.82M $5.532M $9.197M
YoY Change 224.21% -74.9% -80.74%
Operating Profit -$3.358M $3.078M $19.57M
YoY Change -117.16% 383.96% 53.69%
Interest Expense $17.84M $1.000K $45.03M
YoY Change -60.39% -99.7% -374.31%
% of Operating Profit 0.03% 230.09%
Other Income/Expense, Net $2.718M -$15.22M -$792.0K
YoY Change -443.17% -6987.78% -76.32%
Pretax Income $17.10M -$12.14M $24.14M
YoY Change -29.18% -1517.04% -443.58%
Income Tax -$1.091M -$1.871M $38.67M
% Of Pretax Income -6.38% 160.21%
Net Earnings $18.19M -$10.27M -$17.49M
YoY Change -204.02% -2642.82% 222.84%
Net Earnings / Revenue 64.72% -31.26% -34.7%
Basic Earnings Per Share -$0.59
Diluted Earnings Per Share $0.94 -$0.59 -$1.04
COMMON SHARES
Basic Shares Outstanding 17.44M shares 17.36M shares 16.89M shares
Diluted Shares Outstanding 17.38M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $170.3M $190.5M $211.9M
YoY Change -19.62% 56.91% -37.89%
Cash & Equivalents $22.95M $19.28M $45.01M
Short-Term Investments $147.4M $171.2M $166.9M
Other Short-Term Assets $2.657M $2.097M $3.399M
YoY Change -21.83% -80.49% -27.23%
Inventory $23.97M $25.39M $13.29M
Prepaid Expenses $1.182M $1.132M
Receivables $32.92M $36.00M $30.42M
Other Receivables $6.395M $0.00 $4.614M
Total Short-Term Assets $237.4M $254.0M $263.6M
YoY Change -9.93% 15.23% -43.28%
LONG-TERM ASSETS
Property, Plant & Equipment $15.61M $16.18M $12.48M
YoY Change 25.04% -51.59% -39.14%
Goodwill $103.4M $103.8M $105.7M
YoY Change -2.18% -42.73% -41.68%
Intangibles $299.6M $314.8M $342.5M
YoY Change -12.51% -39.1% -37.85%
Long-Term Investments $12.60M $13.99M $0.00
YoY Change
Other Assets $5.923M $8.426M $4.736M
YoY Change 25.06% 34.19% 72.78%
Total Long-Term Assets $549.8M $515.2M $499.1M
YoY Change 10.16% -37.94% -40.08%
TOTAL ASSETS
Total Short-Term Assets $237.4M $254.0M $263.6M
Total Long-Term Assets $549.8M $515.2M $499.1M
Total Assets $787.2M $769.2M $762.7M
YoY Change 3.22% -26.78% -41.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.427M $2.475M $5.307M
YoY Change -54.27% -84.42% -36.84%
Accrued Expenses $12.47M $10.64M $15.68M
YoY Change -20.5% -45.0% -10.8%
Deferred Revenue $1.222M $355.0K
YoY Change 244.23% -96.77%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $7.000K $0.00 $76.74M
YoY Change -99.99% -100.0% 166726.09%
Total Short-Term Liabilities $16.78M $15.73M $98.81M
YoY Change -83.02% -88.37% 137.15%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $27.76M $43.67M $21.97M
YoY Change 26.37% 98.96% -29.09%
Total Long-Term Liabilities $27.76M $43.67M $21.97M
YoY Change 26.37% 98.96% -29.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.78M $15.73M $98.81M
Total Long-Term Liabilities $27.76M $43.67M $21.97M
Total Liabilities $86.30M $101.3M $165.2M
YoY Change -47.75% -56.75% -65.33%
SHAREHOLDERS EQUITY
Retained Earnings $503.0M $484.8M $450.9M
YoY Change 11.57% 3.52% 0.39%
Common Stock $18.00K $18.00K $17.00K
YoY Change 5.88% 5.88% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $700.9M $667.9M $597.5M
YoY Change
Total Liabilities & Shareholders Equity $787.2M $769.2M $762.7M
YoY Change 3.22% -26.78% -41.22%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q4
OPERATING ACTIVITIES
Net Income $18.19M -$10.27M -$17.49M
YoY Change -204.02% -2642.82% 222.84%
Depreciation, Depletion And Amortization $8.916M $8.600M $8.539M
YoY Change 4.42% -36.19% -35.16%
Cash From Operating Activities $8.065M $7.600M $53.47M
YoY Change -84.92% -62.91% 93.44%
INVESTING ACTIVITIES
Capital Expenditures $50.75M $10.90M $2.131M
YoY Change 2281.28% -351.79% -197.08%
Acquisitions
YoY Change
Other Investing Activities $40.46M -$8.600M -$5.153M
YoY Change -885.19% -136.59% -84.63%
Cash From Investing Activities -$10.28M -$19.50M -$7.284M
YoY Change 41.19% -201.69% -79.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.315M 3.200M -5.298M
YoY Change -200.32% -107.84% -227.23%
NET CHANGE
Cash From Operating Activities 8.065M 7.600M 53.47M
Cash From Investing Activities -10.28M -19.50M -7.284M
Cash From Financing Activities 5.315M 3.200M -5.298M
Net Change In Cash 3.096M -8.700M 40.89M
YoY Change -92.43% 647.42% -1146.58%
FREE CASH FLOW
Cash From Operating Activities $8.065M $7.600M $53.47M
Capital Expenditures $50.75M $10.90M $2.131M
Free Cash Flow -$42.68M -$3.300M $51.34M
YoY Change -183.13% -113.3% 72.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
2097000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3399000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
253994000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
263601000 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8530000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8530000 usd
CY2023Q3 lgnd Commercial License Rights
CommercialLicenseRights
6602000 usd
CY2022Q4 lgnd Commercial License Rights
CommercialLicenseRights
10182000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16178000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12482000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6235000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10914000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
3566000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
4095000 usd
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
13985000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
0 usd
CY2023Q3 us-gaap Equity Securities Fvni Noncurrent
EquitySecuritiesFVNINoncurrent
33097000 usd
CY2022Q4 us-gaap Equity Securities Fvni Noncurrent
EquitySecuritiesFVNINoncurrent
0 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8426000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4736000 usd
CY2023Q3 us-gaap Assets
Assets
769226000 usd
CY2022Q4 us-gaap Assets
Assets
762668000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2475000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5307000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10635000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15681000 usd
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
1204000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
0 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
497000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
670000 usd
CY2023Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
76695000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
916000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
457000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
15727000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
98810000 usd
CY2023Q3 lgnd Liability For Contingent Value Rights
LiabilityForContingentValueRights
3515000 usd
CY2022Q4 lgnd Liability For Contingent Value Rights
LiabilityForContingentValueRights
3456000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
32586000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
30615000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5832000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10336000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
43670000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
21966000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
101330000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
165183000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17421000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17421000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16951000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16951000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
18000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
17000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
183994000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
147590000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-944000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-984000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
484828000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
450862000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
667896000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
597485000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
769226000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
762668000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32868000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
59221000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
103213000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
145863000 usd
CY2023Q3 us-gaap Cost Direct Material
CostDirectMaterial
3485000 usd
CY2022Q3 us-gaap Cost Direct Material
CostDirectMaterial
14153000 usd
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
25316000 usd
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
25698000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5532000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9239000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19049000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26885000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14656000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14920000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36798000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38931000 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
31911000 usd
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
46880000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
90034000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
122727000 usd
CY2023Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
2121000 usd
CY2022Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
2121000 usd
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3078000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
12341000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
15300000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
23136000 usd
CY2023Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-13184000 usd
CY2022Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-923000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
30340000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-15709000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2263000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
591000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
6018000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1023000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
1000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
332000 usd
us-gaap Interest Expense
InterestExpense
525000 usd
us-gaap Interest Expense
InterestExpense
1559000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4300000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
677000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4570000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4980000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15222000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
31263000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11265000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12144000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12354000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
46563000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11871000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1871000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2709000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10932000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2556000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-10273000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
9645000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
35631000 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-9241000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10273000 usd
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.55
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.10
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-1.49
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.97
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.94
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17380000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16888000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17241000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16860000 shares
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.59
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.56
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.00
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.54
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.54
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.09
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-1.47
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.93
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17380000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17132000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17784000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17128000 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10273000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
404000 usd
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
23000 usd
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
6000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
40000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-143000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10250000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
410000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
34006000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16019000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
597485000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-762000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5931000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
49000 usd
CY2023Q1 lgnd Adjustments To Additional Paid In Capital Increase Due To Separation
AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation
1665000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
41949000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
646317000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
9110000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7207000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-32000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
23000 usd
CY2023Q3 lgnd Adjustments To Additional Paid In Capital Tax Return To Provision
AdjustmentsToAdditionalPaidInCapitalTaxReturnToProvision
3085000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10273000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
667896000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
821159000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9044000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-114000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-15385000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
793192000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
604000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9499000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-35000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-895000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
802365000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
724000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12597000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
6000 usd
CY2022Q3 lgnd Adjustments To Additional Paid In Capital Warrant And Bond Hedge Unwind Transactions
AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
202000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
404000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
816298000 usd
us-gaap Net Income Loss
NetIncomeLoss
33966000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15876000 usd
lgnd Non Cash Change In Estimated Fair Value Of Contingent Value Rights
NonCashChangeInEstimatedFairValueOfContingentValueRights
-132000 usd
lgnd Non Cash Change In Estimated Fair Value Of Contingent Value Rights
NonCashChangeInEstimatedFairValueOfContingentValueRights
1378000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27605000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40399000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
938000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-75000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
159000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
639000 usd
lgnd Amortization Of Commercial License And Other Economic Rights
AmortizationOfCommercialLicenseAndOtherEconomicRights
-883000 usd
lgnd Amortization Of Commercial License And Other Economic Rights
AmortizationOfCommercialLicenseAndOtherEconomicRights
-163000 usd
lgnd Current And Expected Credit Loss Adjustment
CurrentAndExpectedCreditLossAdjustment
3190000 usd
lgnd Current And Expected Credit Loss Adjustment
CurrentAndExpectedCreditLossAdjustment
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
924000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
2121000 usd
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
4192000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
20022000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
31140000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-6761000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
25570000 usd
lgnd Gain Loss On Short Term Investments
GainLossOnShortTermInvestments
30340000 usd
lgnd Gain Loss On Short Term Investments
GainLossOnShortTermInvestments
-15709000 usd
lgnd Finance Lease And Operating Lease Right Of Use Asset Amortization
FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization
1231000 usd
lgnd Finance Lease And Operating Lease Right Of Use Asset Amortization
FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization
4535000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
215000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-45000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5436000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20550000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11577000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-10702000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7461000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-405000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5818000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
15111000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
226000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5182000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-918000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
17000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
899000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1654000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
41512000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
84378000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
107262000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
39052000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
96318000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
202552000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
37941000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
24830000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
10405000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3104000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15792000 usd
lgnd Payments To Contingent Value Right Holders Investing Activity
PaymentsToContingentValueRightHoldersInvestingActivity
0 usd
lgnd Payments To Contingent Value Right Holders Investing Activity
PaymentsToContingentValueRightHoldersInvestingActivity
960000 usd
lgnd Proceeds From Commercial License Rights
ProceedsFromCommercialLicenseRights
349000 usd
lgnd Proceeds From Commercial License Rights
ProceedsFromCommercialLicenseRights
0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-80000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1398000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
170908000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
76854000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
260949000 usd
us-gaap Proceeds From Hedge Financing Activities
ProceedsFromHedgeFinancingActivities
202000 usd
lgnd Payments To Contingent Value Right Holders Financing Activity
PaymentsToContingentValueRightHoldersFinancingActivity
0 usd
lgnd Payments To Contingent Value Right Holders Financing Activity
PaymentsToContingentValueRightHoldersFinancingActivity
1545000 usd
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
0 usd
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
4171000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-40000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-42000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-65262000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-25148000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15406000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45006000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19522000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19858000 usd
us-gaap Interest Paid Net
InterestPaidNet
288000 usd
us-gaap Interest Paid Net
InterestPaidNet
1139000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
10000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
6630000 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
583000 usd
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
lgnd Business Combination Acquisition Cost Incurred But Not Yet Paid
BusinessCombinationAcquisitionCostIncurredButNotYetPaid
1013000 usd
lgnd Business Combination Acquisition Cost Incurred But Not Yet Paid
BusinessCombinationAcquisitionCostIncurredButNotYetPaid
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
409000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3626000 usd
lgnd Accrued Inventory Purchases
AccruedInventoryPurchases
521000 usd
lgnd Accrued Inventory Purchases
AccruedInventoryPurchases
7676000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
40000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-143000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div>
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32868000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
59221000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
103213000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
145863000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
152299000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
34000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5786000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
146547000 usd
CY2023Q3 lgnd Debt Securities Available For Sale And Equity Securities Fvni
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
171227000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
108778000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
415000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5451000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
103742000 usd
CY2022Q4 lgnd Debt Securities Available For Sale And Equity Securities Fvni
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
166864000 usd
lgnd Equity Securities Fvni Share Sold In Period
EquitySecuritiesFVNIShareSoldInPeriod
4500000 shares
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
37200000 usd
CY2023Q3 lgnd Equity Securities Fvni Share Sold In Period
EquitySecuritiesFVNIShareSoldInPeriod
0 shares
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
71095000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
71070000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
6966000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
6927000 usd
CY2023Q3 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
78061000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
77997000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
48 position
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
100000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2023Q3 lgnd Covid19 Accounts Receivable Allowance For Credit Loss Period Increase Decrease
COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
100000 usd
lgnd Covid19 Accounts Receivable Allowance For Credit Loss Period Increase Decrease
COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
100000 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2022Q3 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2023Q3 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2023Q3 us-gaap Goodwill
Goodwill
103770000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
105673000 usd
CY2023Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
418613000 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
448128000 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
900000 usd
CY2023Q3 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
900000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2890000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6201000 usd
CY2023Q3 lgnd Accrued Subcontractor Expenses Current
AccruedSubcontractorExpensesCurrent
1966000 usd
CY2022Q4 lgnd Accrued Subcontractor Expenses Current
AccruedSubcontractorExpensesCurrent
1756000 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3229000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
662000 usd
CY2023Q3 lgnd Accrued Customer Deposits Current
AccruedCustomerDepositsCurrent
621000 usd
CY2022Q4 lgnd Accrued Customer Deposits Current
AccruedCustomerDepositsCurrent
621000 usd
CY2023Q3 lgnd Accrued Supplier Expenses Current
AccruedSupplierExpensesCurrent
303000 usd
CY2022Q4 lgnd Accrued Supplier Expenses Current
AccruedSupplierExpensesCurrent
634000 usd
CY2023Q3 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
0 usd
CY2022Q4 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
12000 usd
CY2023Q3 lgnd Licensee Accrual Current
LicenseeAccrualCurrent
45000 usd
CY2022Q4 lgnd Licensee Accrual Current
LicenseeAccrualCurrent
3989000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1581000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1806000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10635000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15681000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
6884000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.043
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.447
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y2M12D
CY2023Q3 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2023Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17380000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17380000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4762000 shares
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
lgnd Deferred Tax Assets Adjustments
DeferredTaxAssetsAdjustments
-1700000 usd
CY2010Q1 lgnd Number Of Contingent Value Rights Series
NumberOfContingentValueRightsSeries
4 cvr
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
900000 usd
CY2023Q3 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
900000 usd
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2022Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2022Q3 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2021 lgnd Payments To Unwind Warrants
PaymentsToUnwindWarrants
18400000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.154
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.219
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.235
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.215
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2991473 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
61.31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
518332 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
73.21
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
362926 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
44.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
338742 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
65.09
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2808137 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
65.29
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1800000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
64.22
CY2023Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 usd
CY2023Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
50000000 usd
lgnd Lessee Increase Decrease In Operating Lease Assets Due To Modification
LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification
1100000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
1100000 usd
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
lgnd-20230930_cal.xml Edgar Link unprocessable
0000886163-23-000086-index-headers.html Edgar Link pending
0000886163-23-000086-index.html Edgar Link pending
0000886163-23-000086.txt Edgar Link pending
0000886163-23-000086-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lgnd-20230930.htm Edgar Link pending
lgnd-20230930.xsd Edgar Link pending
lgnd-20230930_g1.jpg Edgar Link pending
lgnd_93023exhibit311.htm Edgar Link pending
lgnd_93023exhibit312.htm Edgar Link pending
lgnd_93023exhibit321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
lgnd-20230930_def.xml Edgar Link unprocessable
lgnd-20230930_lab.xml Edgar Link unprocessable
lgnd-20230930_pre.xml Edgar Link unprocessable
lgnd-20230930_htm.xml Edgar Link completed
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending